Quoin Pharmaceuticals Ltd.
13F holders, Q4 2024 (December 31)14holders +7
7new positions
2sold out
1famous investor
$0.65avg. 13F price*
At the end of Q4 2024, 14 institutions reported holding Quoin Pharmaceuticals Ltd. in their 13F filings, up 7 from Q3 2024. 7 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($345K), Altium Capital Management LLC ($184K) and Ikarian Capital, LLC ($179K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Quoin Pharmaceuticals Ltd.
- CUSIP
- 74907L300
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $850K |
| Exits | 2 | $13K |
All 13F filers, Q3 2024 → Q4 2024: 1,425,190 shares bought and 43,858 shares sold, net +1,381,332 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Armistice Capital, LLC | 0.01% | New | 530,000 | $345K |
| Altium Capital Management LLC | 0.06% | New | 282,249 | $184K |
| Ikarian Capital, LLC | 0.05% | New | 275,000 | $179K |
| Renaissance Technologies | 0.00% | Add +244.1% | 133,122 | $87K |
| Boothbay Fund Management, LLC | 0.00% | New | 80,712 | $53K |
| Apollon Wealth Management, LLC | 0.00% | New | 80,025 | $52K |
| Two Sigma Securities, LLC | 0.01% | Add +64.9% | 52,526 | $34K |
| XTX Topco Ltd | 0.00% | New | 31,047 | $20K |
| HRT Financial LP | 0.00% | New | 27,714 | $18K |
| Raymond James Financial Inc. | 0.00% | — | 25,119 | $16K |
| Rhumbline Advisers | 0.00% | Add +16.1% | 24,126 | $16K |
| UBS Group AG | 0.00% | Reduce -79.1% | 4,773 | $3K |
| SBI Securities Co., Ltd. | 0.00% | — | 24 | $16 |
| Raiffeisen Bank International AG | 0.00% | — | 17 | $11 |
"% of holder's portfolio" is QUOIN PHARMACEUTICALS LTD's weight in each manager's 13F, not the share of Quoin Pharmaceuticals Ltd. the manager owns.